Biotech Decoded
Biotech Decoded takes listeners behind the scenes of the biotechnology industry. Hosted by Yaron Werber, Biotechnology Analyst, Biotech Decoded looks at the intricacies of managing a successful biotech, from navigating mergers & acquisitions to discussing what it takes to be an effective biotech leader. Guests include management teams from leading biotechnology companies.
Dec 23, 2024
Listen in as Praveen Tipirneni shares stories from his path to becoming Morphic's CEO, the company's sale and invaluable experience realized from his career in biotech.
Nov 14, 2024
Jean Hynes discusses her career evolution to become CEO of Wellington Management. Listen to her two key pieces of advice for young women seeking to become a leader.
Aug 07, 2024
We hear from Jeff Solomon about his career in Wall Street and offers experience as an inspirational leader. He also shares insight about the state of biotech and the healthcare sector.
Jul 05, 2024
Are biotech investments in a long-term funk, a short-term slump or ready to rise again? Explore the investment strategy of Logos Capital and how the health care industry is adapting.
Apr 03, 2024
Luke Timmerman discusses the Timmerman Traverse, which brings together biotech professionals who undertake climbs to benefit organizations battling cancer, poverty and sickle cell disease.
Jul 12, 2023
How the Inflation Reduction Act (IRA) can impact biotech innovation by reshaping drug development strategies, affecting pricing negotiations, and incentivizing a shift towards certain drug categories.
Apr 17, 2023
Seagen, Gilead and Amgen leaders explore C-suite accountability, the difference between functional and company leadership, thinking like a CEO and traits of successful teams.
Dec 16, 2022
Women leaders at biotech VCs discuss how companies adapt to new market realities, as well as the progress and opportunities of gender equality in the industry.
Oct 24, 2022
T. Rowe Price and Surveyor analysts share dos and don’ts for IR to effectively communicate with the buy side and sell side including facilitating dialogue and managing expectations.
Sep 08, 2022
Lundbeck President & CEO compares smaller US biotechs to global pharmaceutical companies and discusses long-term sustainability, social responsibility and successful collaboration elements.
Jul 28, 2022
Internal alignment is crucial for successful biotech transactions. Insights include risk-taking, spending discipline, R&D challenges and evolving collaborations in the biotech space.
May 09, 2022
Women biotech leaders share experiences, stress peer networks and reveal insights for successful M&A—including board/C-suite roles, value creation, diversity, and transparency.
Feb 24, 2022
Behzad Aghazadeh and Alex Denner discuss the importance of human capital for operational excellence, how boards operate, and unlocking value as an activist investor by working at the board level.
Feb 09, 2022
Gilead’s SVP of Corporate Development gives an insider's view of the deal-making process, including deal execution, oncology M&A trends, identifying acquisition targets, and negotiation insights.
Feb 04, 2022
Explore building early-stage companies amid rapid biotech innovation with Jean-Francois Formela, Partner at Atlas Venture and Otello Stampacchia, Founder of Omega Funds.
Oct 05, 2021
GV General Partner David Schenkein explores how external innovation helps large and small biotech companies succeed, "win-win" deals and how deal term structure facilitates effective collaborations.
Sep 28, 2021
Biotech industry leaders formerly of Celgene discuss collaboration, balancing internal/external innovation, and fostering partnerships through "deal-friendly" culture.
Aug 26, 2021
Roche & Pfizer leaders share insights on valuations, risk-taking, internal alignment, and humility in transactions, along with a behind-the-scenes views of deal processes.